Enhancing Evolution: The Transhuman Case for Gene Doping

Authored by: Andy Miah

Routledge Handbook of Sport and Exercise Systems Genetics

Print publication date:  April  2019
Online publication date:  March  2019

Print ISBN: 9781138504851
eBook ISBN: 9781315146287
Adobe ISBN:

10.4324/9781315146287-40

 Download Chapter

 

Abstract

The conventional view on gene doping is that it should be treated like other forms of doping, both in scientific and ethical terms, as evidenced by its inclusion within the World Anti-Doping Code back in 2003 (World Anti-Doping Agency (WADA), 2003). The basis for this position is that, like other forms of doping, gene doping involves the use of medical technologies for nontherapeutic biological modifications, as described in WADA’s initial terminology banning gene doping, which described it as:

M3: Gene Doping

The non-therapeutic use of cells, genes, genetic elements, or the modulation of gene expression, having the capacity to enhance athlete performance.

(WADA, 2003)

 Cite
Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.